Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Electroninks is a private advanced materials company that develops and manufactures particle-free metal complex conductive inks for next-generation electronics. Its products are used in semiconductor packaging, printed circuit board manufacturing, consumer electronics, wearables, and some medical device applications rather than in therapeutics or drug development. The company markets silver, gold, platinum, nickel, copper, and dielectric ink products and also offers related solutions such as CircuitJet, CircuitSeed, CircuitShield, and CircuitWrap for additive manufacturing and advanced packaging workflows. Electroninks emphasizes high-volume manufacturing compatibility, lower-temperature processing, high conductivity, and more sustainable manufacturing relative to conventional nanoparticle inks and plating methods. The business is best categorized as an electronics materials/platform company with limited adjacency to healthcare through medical device enablement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Electroninks.